Louis Picker, M.D., and his team have been awarded a $25 million grant from the Bill & Melinda Gates Foundation that will spur their work on a vaccine candidate against HIV. This work is based on previous findings that this candidate, which uses cytomegalovirus as a vector, can boost effector memory T cells to successfully target simian immunodeficiency virus. This new award will test the safety of a prototype human version of the vaccine in a phase I clinical trial in humans, as well as optimize the vaccine for phase II trials. Read the OHSU media release here, and here’s the Oregonian story.
Welcome to the Research News Blog
OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.
Recent Blog Posts
- Biomedical Innovation Program – moving innovations to market
- 2016 Lifesavers Breakfast, Nov. 16
- New research volunteer registry: Volunteer information and biorepository
- Rachel Dresbeck on NIH director to give annual Mark O. Hatfield Lecture, Oct. 24
- Laurie J LePore on NIH director to give annual Mark O. Hatfield Lecture, Oct. 24
- Rachel Dresbeck on Learn about volunteering overseas at OHSU Global health fair, Oct. 6
awards basic research brown bag cancer career development clinical research collaboration community conference cores Discoveries eIRB event events funding funding focus funding opportunities Funding Opportunity graduate students Integrity internal funding IRB Notes junior faculty lecture Limited Submission NIH OCTRI OHSU faculty OHSU Knight Cancer Institute OHSU Researchers ONPRC postdoctoral fellows research Research Administration research career development research integrity Research Resources research week seminar technology training translational research TTBD visiting speaker workshop